Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Change in Inventory (2016 - 2025)

Ocular Therapeutix has reported Change in Inventory over the past 12 years, most recently at $76000.0 for Q4 2025.

  • Quarterly results put Change in Inventory at $76000.0 for Q4 2025, down 88.03% from a year ago — trailing twelve months through Dec 2025 was $524000.0 (down 28.71% YoY), and the annual figure for FY2025 was $524000.0, down 28.71%.
  • Change in Inventory for Q4 2025 was $76000.0 at Ocular Therapeutix, down from $449000.0 in the prior quarter.
  • Over the last five years, Change in Inventory for OCUL hit a ceiling of $635000.0 in Q4 2024 and a floor of -$230000.0 in Q2 2025.
  • Median Change in Inventory over the past 5 years was $64500.0 (2023), compared with a mean of $118150.0.
  • Biggest five-year swings in Change in Inventory: surged 1432.14% in 2022 and later tumbled 751.85% in 2025.
  • Ocular Therapeutix's Change in Inventory stood at $28000.0 in 2021, then surged by 1432.14% to $429000.0 in 2022, then plummeted by 88.81% to $48000.0 in 2023, then surged by 1222.92% to $635000.0 in 2024, then plummeted by 88.03% to $76000.0 in 2025.
  • The last three reported values for Change in Inventory were $76000.0 (Q4 2025), $449000.0 (Q3 2025), and -$230000.0 (Q2 2025) per Business Quant data.